Vasoplegic syndrome in patients undergoing heart transplantation

被引:1
|
作者
Qin, Tong-xin [1 ]
Yao, Yun-tai [2 ]
机构
[1] Shanxian Cent Hosp, Dept Anesthesiol, Heze, Peoples R China
[2] Fuwai Hosp, Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis,Dept Anesthesiol, Beijing, Peoples R China
来源
FRONTIERS IN SURGERY | 2023年 / 10卷
关键词
vasoplegic syndrome; heart transplant; risk factor; onset time; treatment; METHYLENE-BLUE; RISK-FACTORS; CARDIOPULMONARY BYPASS; PULMONARY-HYPERTENSION; HYDROXOCOBALAMIN; EPIDEMIOLOGY; INFLAMMATION; DEPRESSION; SURGERY; HYPOTHERMIA;
D O I
10.3389/fsurg.2023.1114438
中图分类号
R61 [外科手术学];
学科分类号
摘要
ObjectivesTo summarize the risk factors, onset time, and treatment of vasoplegic syndrome in patients undergoing heart transplantation. MethodsThe PubMed, OVID, CNKI, VIP, and WANFANG databases were searched using the terms "vasoplegic syndrome," "vasoplegia," "vasodilatory shock," and "heart transplant*," to identify eligible studies. Data on patient characteristics, vasoplegic syndrome manifestation, perioperative management, and clinical outcomes were extracted and analyzed. ResultsNine studies enrolling 12 patients (aged from 7 to 69 years) were included. Nine (75%) patients had nonischemic cardiomyopathy, and three (25%) patients had ischemic cardiomyopathy. The onset time of vasoplegic syndrome varied from intraoperatively to 2 weeks postoperatively. Nine (75%) patients developed various complications. All patients were insensitive to vasoactive agents. ConclusionsVasoplegic syndrome can occur at any time during the perioperative period of heart tranplantation, especially after the discontinuation of bypass. Methylene blue, angiotensin II, ascorbic acid, and hydroxocobalamin have been used to treat refractory vasoplegic syndrome.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Orthotopic heart transplantation in patients with Marfan syndrome
    Knosalla, Christoph
    Weng, Yu-guo
    Hammerschmidt, Robert
    Pasic, Miralem
    Schmitt-Knosalla, Isabela
    Grauhan, Onnen
    Dandel, Michael
    Lehmkuhl, Hans B.
    Hetzer, Roland
    ANNALS OF THORACIC SURGERY, 2007, 83 (05): : 1691 - 1696
  • [32] Contemporary Outcomes in Patients with Cardiac Amyloidosis Undergoing Heart Transplantation
    Alexander, K.
    Barrett, C.
    Dobos, K.
    Cheng, P.
    Liao, R.
    Wheeler, M.
    Liedtke, M.
    Weisshaar, D.
    Witteles, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S215 - S215
  • [33] Postoperative Outcomes of Patients with Chagas Cardiomyopathy Undergoing Heart Transplantation
    Martino, M.
    Ebner, B.
    Munagala, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S257 - S257
  • [34] Sex differences in patients undergoing heart transplantation and LVAD therapy
    Rubinstein, Gal
    Lotan, Dor
    Moeller, Cathrine M.
    DeFilippis, Ersilia M.
    Slomovich, Sharon
    Oren, Daniel
    Yuzefpolskaya, Melana
    Sayer, Gabriel
    Uriel, Nir
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2022, 20 (11) : 881 - 894
  • [35] Experience with Eculizumab in Highly Sensitized Patients Undergoing Heart Transplantation
    Dhillon, M.
    Patel, J.
    Kittleson, M.
    Chang, D.
    Patel, N.
    Singer-Englar, T.
    Hamilton, M.
    Czer, L.
    Megna, D.
    Kobashigawa, J. A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S92 - S92
  • [36] Outcomes in Patients With Symptomatic Cerebrovascular Disease Undergoing Heart Transplantation
    Patlolla, Vishnu
    Mogulla, Vanajakshi
    DeNofrio, David
    Konstam, Marvin A.
    Krishnamani, Rajan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (10) : 1036 - 1041
  • [37] Cost and Factors Associated With the Hospitalization of Patients Undergoing Heart Transplantation
    Carvalho Barreto, Maynara Fernanda
    Gomes Dellaroza, Mara Solange
    Parron Fernandes, Karen Barros
    Cavalcante Pissinati, Paloma de Souza
    Quina Galdino, Maria Jose
    Fernandez Lourenco Haddad, Maria do Carmo
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (10) : 3412 - 3417
  • [38] Letter on 'Idarucizumab for the reversal of dabigatran in patients undergoing heart transplantation'
    Kalmanovich, Eran
    Gaudard, Philippe
    Roubille, Francois
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (06) : 818 - 818
  • [39] Modulation of Nesfatin, Visfatin and Resistin in Patients Undergoing Heart Transplantation
    Beiras-Fernandez, A.
    Reinwand, S.
    Kreth, S.
    Beiras, A.
    Moritz, A.
    Werner, I.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S189 - S189
  • [40] Does warfarin increase bleeding in patients undergoing heart transplantation?
    Vega, JD
    Levy, JH
    Buist, NN
    Allen, MB
    Smith, AL
    Lu, W
    Kanter, KR
    TRANSPLANTATION, 1999, 67 (07) : S105 - S105